Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy.

Andrea AmstadEleftherios PapagiannoulisAlmut SchererAndrea Rubbert-RothAxel FinckhRuediger MuellerJean DudlerBurkhard MöllerPeter M VilligerMartin M P SchulzDiego Kyburz

Published in: Rheumatology (Oxford, England) (2022)

In a real-world population of RA patients who discontinued treatment with a JAKi, switching to another JAKi resulted in a higher drug retention than switching to a TNFi. A switch to a second JAKi seems an effective therapeutic option.

Keyphrases

rheumatoid arthritis
disease activity
drug induced
emergency department
interstitial lung disease
stem cells
systemic sclerosis
smoking cessation